CRYGD encodes gamma-D crystallin, a major structural protein constituent of the vertebrate eye lens 1. As a dominant lens component, CRYGD maintains lens transparency and is essential for normal visual perception and lens fiber cell differentiation [GO Annotations]. The protein consists of two structurally similar domains, and mutations disrupting domain architecture compromise lens protein solubility and function. CRYGD mutations cause congenital cataracts through multiple mechanisms: the R36P mutation reduces soluble protein levels without affecting insoluble fractions or triggering proteasomal degradation 2, while the recurrent P24T mutation causes bilateral, non-progressive coralliform cataracts in 83.3% of affected Chinese families 3. Other mutations including R58H, R77S, and nonsense variants (W157*, W131*, R140*) result in distinct cataract phenotypes ranging from anterior polar coronary to nuclear and lamellar presentations 456. Evolutionary analysis reveals that cataractogenic mutations sometimes revert to ancestral protein sequences, with compensatory changes in structurally reciprocal domains potentially modulating pathogenic effects 1. CRYGD ranks among the top three genes (alongside PAX6 and GJA8) implicated in nonsyndromic congenital cataract genetics, accounting for approximately 27% of identified variants 76. Intrafamilial clinical heterogeneity can occur with identical CRYGD mutations, suggesting additional modifying factors influence phenotypic expression 4.